A new review suggests it’s time to road test the point-of-care screening tools doctors use to identify brain dysfunction in patients with advanced liver disease.

A Michigan Medicine researcher outlines the relationship between obesity, nonalcoholic steatohepatitis cirrhosis and a rising liver transplant burden.

Noninvasive tests haven’t replaced liver biopsies, but they have sharply reduced the need for them. Two Michigan Medicine experts examine the debate in a new paper.